Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.
Haematologica
; 106(7): 1857-1866, 2021 07 01.
Article
in En
| MEDLINE
| ID: mdl-32499243
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Myeloma
Limits:
Animals
/
Humans
Language:
En
Journal:
Haematologica
Year:
2021
Document type:
Article